Ovid Therapeutics Inc. (OVID) OV329 Topline Results Webcast from the Phase 1 Healthy Volun

Group 1 - The call is hosted by Victoria Fort, Senior Vice President of Corporate Affairs and Corporate Strategy, to discuss the Top Line OV329 Phase I readout [1][2] - Key executives participating in the call include Dr. Jeremy Levin (Chairman and CEO), Meg Alexander (President and COO), Jeff Rona (Chief Business and Financial Officer), and Zhong Zhong (Chief Scientific Officer) [2] - The company will be making forward-looking statements regarding future expectations, plans, and prospects, which are subject to risks and uncertainties [3]